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Abstract
Background: The question "Where have you been?" is a common one asked by doctors in
Northern Europe and America when faced with clinical symptoms not typical of their country. This
question must also arise in the clinics of developing countries in which non-autochthonous cases
such as the one described here can appear. Important outbreaks of Leishmania infantum have been
recorded in the last decade in several Latin American countries but its presence has not yet been
recorded in Argentina. We report the first case of visceral leishmaniasis owing to L. infantum in this
country.
Case presentation: A 71-year-old Spanish woman who has been living in Mendoza, Argentina,
during the last 40 years presented with a history of high fever and shivering, anemia, leukopenia and
splenomegaly over two years. Argentinian doctors did not suspect visceral leishmaniasis even when
the histological analysis revealed the presence of "intracytoplasmatic spheroid particles compatible
with fungal or parasitic infection". After a serious deterioration in her health, she was taken to Spain
where she was evaluated and visceral leishmaniasis was established. Specific identification of the
parasite was done by PCR-ELISA, isoenzyme electrophoresis and RAPD-PCR.
Conclusion: We would like to point out that: i) cases such as the one described here, which
appear in non-endemic areas, can pass unnoticed by the clinical physician. ii) in countries in which
these introduced cases reside, in-depth parasitological studies are required into vectors and
possible reservoirs to rule out the rare case of local infection and, once infection has taken place,
to ensure that this does not spread by anthroponotic transmission or a competent reservoir.
Background
Leishmaniasis is a parasitic infection caused by the obli-
gate intracellular protozoa Leishmania and is transmitted
by the bite of the sand fly. Leishmania currently infects
about 12 million people in 88 countries, with an approx-
imated incidence of 0.5 million cases of visceral
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leishmaniasis and 1.5 million cases of cutaneous leishma-
niasis http://www.who.int/tdr/diseases/leish/disea
seinfo.htm. The different clinical forms of leishmaniasis
are the result of infection by different species of the para-
site. Visceral leishmaniasis, fatal if left untreated, is typi-
cally caused by L. donovani, L. infantum and L. chagasi
(synonimous to L. infantum). Visceral leishmaniasis due
to L. infantum is a zoonosis in which dogs are the main
reservoirs. In adition to the conventional zoonotic cycle,
L. infantum infection could, in some cases, spread follow-
ing an anthroponotic cycle. L. infantum is also responsible
for cutaneous and mucosal leishmaniasis [1-3].
The question "Where have you been?" is a common one
asked by doctors in Northern Europe and America when
faced with clinical symptoms not typical of their country.
There are numerous cases of visceral leishmaniasis and
cutaneous leishmaniasis diagnosed in patients who have
been travelling in the Mediterranean basin or Central or
South America [4-8]. A similar situation occurs with veter-
inary surgeons and canine leishmaniasis. This question
must also arise in the clinics of developing countries in
which non-autochthonous cases such as the one
described here can appear.
Case presentation
A 71-year old Spanish woman who has been living in
Mendoza, Argentina, during the last 40 years. She has
always been in good health and does not take regular
medication. In June, 1998, she began to present high fever
and shivering mainly in the evening and poor general
health. She was submitted to in-depth clinical studies in
Mendoza, Argentina, without reaching any definitive
diagnosis. Laboratory examination revealed: haemo-
globin: 9.4 g/dL, WBC: 1600 /mL with 13% lymphocytes
and 4% mononuclear cells, and polyclonal immunoglob-
ulinopathy. She had splenomegaly. She was treated with
antipyretic agents (Metamizol) and empirical antibiotics
(cephalosporines) and in October 1999 was submitted to
splenectomy but continued with the same symptomatol-
ogy. Histopathological study of the spleen revealed
"Giemsa-stained histocytic intracytoplasmatic spheroid
particles compatible with fungal or parasitic infection". In
spite of this diagnosis, Leishmania was not suspected and,
therefore, no specific treatment was prescribed.
After a serious deterioration in her health and on request
of her nephew physician, she was taken to Spain where
she was admitted in May 2000 to the Hospital Virgen de
las Nieves de Granada, where, on the basis of previous
findings, visceral leishmaniasis was suspected. Bone mar-
row puncture was carried out and blood was extracted to
obtain serum. The specific antibody titre against Leishma-
nia, detected by indirect immunofluorescence was 1/1280
[9]. Microscopic observation of Giemsa-stained smears
[10] revealed the presence of amastigotes in bone marrow
and the promastigote form was observed in Minimum
Essential Medium Eagle (Gibco) supplemented with 20%
fetal calf serum [10]. Kinetoplast DNA of L. infantum was
detected in the bone marrow aspirate using PCR-ELISA
[11]. Treatment with GlucantimeR (20 mg/Kg daily for 4
weeks) [12] was followed by complete remission of symp-
toms and the patient returned to Mendoza, Argentina, in
excellent health.
Specific identification of the parasite
PCR-ELISA [11] revealed that the species present was L.
infantum, and after mass culture of the parasites, isoen-
zyme electrophoresis [13] in starch gel identified the
strain (MHOM/?/2000/DP517) as belonging to the
zymodeme MON-27 of L. infantum. This zymodeme dif-
fers from L. infantum MON-1 in the NP1 enzyme that
presents a relative electrophoretic mobility of 130 [14].
Also, the RAPD-PCR technique was applied [15] and
revealed a closer association between the problem strain
and a strain of L. chagasi used as a control (Figure 1).
Discussion
In Argentina, there have been a total of 16 recorded cases
of leishmaniasis with visceral symptomatology since
1923. Of these, 2 were considered to have been imported
from Italy [16] and Yugoslavia [17], one was of unknown
origin [18], and the remaining 13 were autochthonous to
the provinces of Salta, Jujuy, Santiago del Estero and
Chaco (northern Argentina) [19-26]. In these provinces,
tegumentary leishmaniasis (cutaneous, cutaneomucosal
and mucosal leishmaniasis) owing to L  (Viannia)  bra-
ziliensis is endemic [26]. Recently, cases of tegumentary
leishmaniasis caused by L. (Leishmania) amazonensis [27]
have been described. There has also been a case of visceral
leishmaniasis due to L. (Leishmania) mexicana in a patient
with AIDS [28]. Owing to i) the absence of the L. chagasi
vector where the cases appeared in Argentina, ii) geo-
graphical overlap with the region of endemic cutaneous
leishmaniasis, iii) simultaneous symptomatology of tegu-
mentary leishmaniasis and iv) a lack of parasite classifica-
tion in recorded cases of visceral leishmaniasis, it has been
postulated that these could be due to a visceralization of
cutaneous leishmaniasis [26].
L. (Leishmania) chagasi is the etiological agent of visceral
leishmaniasis in the New World and is considered to be
synonymous to L. infantum, the only causal agent of vis-
ceral and tegumentary leishmaniasis in western European
Mediterranean countries. Important outbreaks of L. cha-
gasi have been recorded in the last decade and an increase
in its distribution in several Latin American countries such
as Brazil and Paraguay but its presence has not yet been
recorded in Argentina [26]. The city of Mendoza, (32° 53'
LS, 68° 49' LW) is more than 800 km away from the areaBMC Infectious Diseases 2004, 4:20 http://www.biomedcentral.com/1471-2334/4/20
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of transmission of tegumentary leishmaniasis or from the
last recorded case of leishmaniasis with visceral symp-
tomatology in Argentina in 1989, in a completely differ-
ent ecological region to those where sand fly insect vectors
are found. This could explain why Argentinian doctors did
not suspect this disease even when the histological analy-
sis revealed the presence of intracellular parasites. On the
other hand, sporadic cases of tegumentary leishmaniasis
in migrants, an exotic disease in Mendoza but not in
Argentina, were adequately recorded, diagnosed and
treated by the local health service in Mendoza.
The patient travelled regularly to Spain, although when
she became ill she had not been to this country in the pre-
vious two years. In 1985, she went on holiday to Brazil
and six months before her first symptoms had visited San-
tiago de Cuba (Cuba) and Cancun (Mexico). Every year
she goes to Santiago de Estero (Argentina) for 15–20 days,
a place she had just visited before becoming ill and in
which tegumentary leishmaniasis due to L. (Viannia) bra-
ziliensis is endemic [26,29].
In Mexico there are few cases of visceral leishmaniasis and
these seem to be confined to the states of Chiapas, Guer-
rero, Puebla and Tabasco [1,30]. No case has been
described in the Yucatan Peninsula, the region in which
Cancun, the place visited by the patient, is located. Leish-
maniasis is not endemic in Cuba [1,31] and these two
countries can, therefore, be ruled out as the source of the
infection. It is also unlikely that the infection took place
in Brazil since the patient had not visited this country in
the last 15 years. However, she always visited Spain during
Summer and stayed for several months in regions known
to be endemic for leishmaniasis in the provinces of Gra-
nada, Barcelona and Valencia. It is, therefore, likely that
the patient was infected in Spain because of: i) more
opportunities for infection due to the patient's frequent
and prolonged visits. ii) the enzymatic polymorphism of
the isolate. This belongs to a different zymodeme than
MON-1, the only one identified to date in America, while
there is a clear presence of the L. infantum polymorphism
in Spain [13,15].
Dendrograms constructed using the RAPD technique
agree with those developed from isoenzymatic data for
the separation of species but coincide little for within-spe-
cies data, reflecting the heterogeneity of the strains
belonging to the same zymodeme. Nevertheless, these
RAPD dendrograms reflect a geographical structuration of
the isolates. Figure 1 shows how the isolate DP517 is sep-
arated from the strains of L. infantum isolated from south-
ern Spain, possibly indicating that the infection did not
happen in this Spanish region. In any case, if the patient
had contracted the present infection in Spain this would
Dendrogram Based Nei's Genetic distance: Method = UPGMA Modified from NEIGHBOR procedure of PHYLIP Version 3.5 Figure 1
Dendrogram Based Nei's Genetic distance: Method = UPGMA Modified from NEIGHBOR procedure of PHYLIP Version 3.5. 
(1) are strains isolated from southern Spain: DP74 and DP208 are eastern strains and DP440 and DP510 are central-western 
strains. DP517 is the strain from this case report. L. donovani MON18 is from Portuguese origin.
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correspond to a case of asymptomatic leishmaniasis for at
least the first two years. This would not be very unusual
since it is well known that infection by L. infantum can
exist in a subclinical form in healthy individuals without
a previous background of cutaneous or visceral leishmani-
asis. In fact, in endemic regions there is a remarkably high
proportion of asymptomatic carriers of Leishmania
[32,33]. These asymptomatic individuals could, therefore,
act as reservoirs for the parasite.
On the other hand, the RAPD results show a greater asso-
ciation between this strain and the L. chagasi control that
would favour the infection occurring in Argentina. More-
over, to date the MON-27 zymodeme has only been
found in Italy, a country that the patient has never visited,
but could have been introduced into the country by Ital-
ian immigrants.
However, Lutzomyia longipalpis, the vector of L. chagasi, is
very little represented in Argentina, and has only been
captured more than 1500 km from Mendoza, in the
Misiones province. Neither have other species with vecto-
rial capacity for L. infantum-chagasi in Argentinian terri-
tory been found, and the only sand fly found south of 29°
is limited to a very small area with unique ecological char-
acteristics 1000 km from the patient's place of residence.
No sand flies have been recorded in the captures of insect
vectors made to date in Mendoza nor are there any cases
of autochthonous human or veterinary tegumentary or
visceral leishmaniasis in this Argentinean province. There-
fore, vectorial transmission of visceral leishmaniasis due
to L. infantum-chagasi in Mendoza seems unlikely. On the
other hand, the patient visited annually the province of
Santiago de Estero, endemic for tegumentary leishmania-
sis, with three cases of visceral leishmaniasis in the last few
years, one concomitant with a mucocutaneous leishmani-
asis; although Lutzomyia longipalpis was not found either
in this province nor was there any record of visceral leish-
maniasis in immunocompetent adults or in dogs.
Conclusions
We would like to point out that: i) cases such as the one
described here, which appear in non-endemic areas, can
pass unnoticed by the clinical physician. ii) in countries in
which these introduced cases reside, in-depth parasitolog-
ical studies are required into vectors and possible reser-
voirs to rule out the rare case of local infection and, once
infection has taken place, to ensure that this does not
spread by anthroponotic transmission or a competent
reservoir.
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